This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Patient-Centered Psychopharmacology and Psychosocial Interventions: Treatment Selection and Shared Decision-Making to Enhance Chances for Recovery

John Lauriello, MD

Published: May 12, 2020

Article Abstract

Individuals with schizophrenia can achieve the ultimate goal of treatment—recovery. However, patients are often nonadherent to prescribed medication regimens, leading to relapses and significantly decreasing their chances of ever reaching this goal. By implementing patient-centered assessment and evidence-based pharmacologic and psychosocial interventions, such as LAI antipsychotics, cognitive-behavioral therapy, and motivational interviewing, clinicians can improve medication adherence and enhance the potential for functional recovery.

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

From the Series: The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

To cite: Lauriello J. Patient-centered psychopharmacology and psychosocial interventions: treatment selection and shared decision-making to enhance chances for recovery. J Clin Psychiatry. 2020;81(3):MS19053BR4C.

To share:

© Copyright 2020 Physicians Postgraduate Press, Inc.


Volume: 81

Quick Links: